Dexcom gets FDA nod for its new API integration mobihealthnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mobihealthnews.com Daily Mail and Mail on Sunday newspapers.
Photo: Martin Barraud/Getty Images
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products.
The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche.
Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the software platforms and/or medical devices offered by the diabetes management companies to allow for the collection and sharing of personal health data. We re pleased to work alongside these innovative partners who share our commitment to improving diabetes outcomes by bringing together medicine and digital solutions for the global diabetes community, Marie Schiller, vice president of product development for Connected Care and Insulins at Eli Lilly, said in a statement.